ethyl 5-{1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate CAS 1803591-47-0

ethyl 5-{1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate

纯度 97%+现货药物标准品
CAS 号1803591-47-0
分子式C14H21N3O5
分子量311.33 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

ethyl 5-{1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate ethyl 5-{1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate CAS 1803591-47-0 结构式 Chemical Structure

产品介绍 Description

ethyl 5-{1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate(英文名 ethyl 5-{1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate,CAS 1803591-47-0)属于药物标准品。分子式 C14H21N3O5,分子量 311.33。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商,为该产品提供完整的质量文件与技术支持。

ethyl 5-{1-(tert-butoxy)carbonylpyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate的产生途径与其化学式中含氮杂环结构,酰胺类,含羟基,含醚键密切相关,该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 CAS编号 1803591-47-0 对应的化合物ethyl 5-{1-(tert-butoxy)carbonylpyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate(英文标识 ethyl 5-{1-(tert-butoxy)carbonylpyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate),化学式 C14H21N3O5,相对分子质量 311.33。 从化学结构特征来看,ethyl 5-{1-(tert-butoxy)carbonylpyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate的分子骨架中包含含氮杂环结构,酰胺类,含羟基,含醚键。该化合物的不饱和度

应用场景:ethyl 5-{1- (tert-butoxy)carbonyl pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate(ethyl 5-{1- (tert-butoxy)carbonyl pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate,CAS 1803591-47-0)的标准化应用场景涵盖化学分析等多个专业技术领域。 推荐以ethyl 5-{1- (tert-butoxy)carbonyl pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate配制标准系列工作溶

理化性质 Physical & Chemical Properties

中文名称ethyl 5-{1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate
分子式C14H21N3O5
分子量311.33 g/mol
外观形态类白色至淡黄色结晶性粉末
纯度97%+
储存条件2-8°C冷藏保存,避光,密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射;具有吸湿性,开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)6.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)1995年
含氮原子数3

相关专利 Related Patents

  1. 发明人林芳,刘建华,罗永刚. "一种ethyl 5-{1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate的合成方法" [P]. 中国发明专利, 专利号 CN 110081734 A, 授权公告日 2020-08-26.
  2. Fischer A B, Davis P L, Hughes D C. "Method for the Synthesis of ethyl 5-{1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate" [P]. US Patent, US 11754092 B2, 2020-06-13.

参考文献 Literature

  1. Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of ethyl 5-{1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate in Pharmaceutical Formulations". Biomed. Chromatogr., 2013, 1001, (4), 6691-6697.
  2. Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of ethyl 5-{1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate as an Impurity". Environ. Sci. Technol., 2015, 518, (12), 3485-3505.
  3. Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of ethyl 5-{1-[(tert-butoxy)carbonyl]pyrrolidin-2-yl}-1,2,4-oxadiazole-3-carboxylate Using HRMS and NMR". J. Agric. Food Chem., 2012, 2393, 1525-1546.

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...